MTNB uplist:
Matinas BioPharma Holdings, Inc. (OTCQB:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today that its common stock has been approved for listing on the NYSE MKT. The Companys common stock is expected to begin trading on NYSE MKT under the symbol MTNB beginning on March 2, 2017 . The Companys common stock will continue to trade on the OTCQB until the close of the market on March 1, 2017 .
Solid DD combined with timeliness and conviction is a recipe for profits.